发明公开
- 专利标题： POLYMORPHS OF ATOMOXETIENE HYDROCHLORIDE
- 专利标题（中）： ATOMOXETIEN盐酸盐多晶型
-
申请号： EP05774968.1申请日： 2005-07-21
-
公开(公告)号： EP1768949A2公开(公告)日： 2007-04-04
- 发明人: ARONHIME, Judith , BIANCHI, Stefano , CASTELLI, Eugenio , MANTOVANI, Silvia , COVACSNE-MEZEI, Adrienne
- 申请人： Teva Pharmaceutical Fine Chemicals S.R.L.
- 申请人地址： Strada Statale Briantea, Km 36, No83 23892 Bulciago IT
- 专利权人： Teva Pharmaceutical Fine Chemicals S.R.L.
- 当前专利权人： Teva Pharmaceutical Fine Chemicals S.R.L.
- 当前专利权人地址： Strada Statale Briantea, Km 36, No83 23892 Bulciago IT
- 代理机构： Wong, Kit Yee
- 优先权： US590851P 20040722
- 国际公布： WO2006020348 20060223
- 主分类号： C07C217/48
- IPC分类号： C07C217/48 ; C07C213/10
摘要：
The present invention provides novel crystalline polymorph forms of atomoxetine hydrochloride denominated Forms B and C and methods for their preparation, as well as methods for the preparation of Form A. The present invention provides pharmaceutical compositions that comprise atomoxetine hydrochloride Form B, Form C, or mixtures thereof that can be used to treat attention deficit/ hyperactivity disorder.
信息查询
